MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • MDS Virtual Congress 2020

    Depression in patients with Parkinson’s disease

    M. Lisak, B. Špiljak (Zagreb, Croatia)

    Objective: The objective of this study was to correlate PD severity with depression. Background: ​​​​Depression is the most common psychiatric disorder in patients with PD. In…
  • MDS Virtual Congress 2020

    Microstructural changes in GBA mutation carriers with depression

    H. Wilson, E. de Natale, M. Politis (London, United Kingdom)

    Objective: To investigate structural changes associated with depression in glucocerebrosidase (GBA) mutation carriers. Background: Depression is a common non-motor symptom in Parkinson’s disease (PD); however,…
  • MDS Virtual Congress 2020

    Psychiatric comorbidities in Young Onset Parkinson’s disease

    A. Patwardhan, P. Pal, N. Kamble, R. Yadav (Bangalore, India)

    Objective: The study aims at exploring psychiatric comorbities;namely;anxiety,depression and impulse control disorders(ICD) and their inter relationship in a large cohort of Young onset PD(YOPD)patients. Background:…
  • MDS Virtual Congress 2020

    Depression in Parkinson’s Disease: perspectives from an Australian cohort

    M. Lubomski, R. Davis, C. Sue (Sydney, Australia)

    Objective: This study aimed to identify clinical predictors and management implications for depression in an Australian cohort of Parkinson’s disease (PD) patients. Background: Depression is…
  • MDS Virtual Congress 2020

    Risk of Suicidal Ideation After Deep Brain Stimulation Surgery in Patients with Parkinson’s Disease

    A. Seritan, J. Parad, S. Wang, J. Ostrem, A.M Iosif (San Francisco, CA, USA)

    Objective: To explore the association of preoperative risk factors with postoperative suicidal ideation in patients with Parkinson’s disease (PD) who had deep brain stimulation (DBS)…
  • MDS Virtual Congress 2020

    Depression in various forms of parkinsonism and striatal hyperkinesis

    R. Matmurodov, K.h Khalimova, E. Abduqodirov (Tashkent, Uzbekistan)

    Objective: To examine of the degree of depression in various forms of Parkinsonism and striatal hyperkinesis Background: Depression is the basis of affective disorders. Almost…
  • MDS Virtual Congress 2020

    Clinical Features of Depressive Disorders in Parkinson’s Disease: Possibilities of their Correction

    A. Umarov, G. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: Nowadays Parkinson's disease is one the problems of medicine which is waiting its solution. Background: The aim of our study was to examine the…
  • MDS Virtual Congress 2020

    Cognitive function and depressive symptoms among older adults with serious difficulty walking in Americans

    Y. Zhang, Y. Qu, Q. Niu (Xi’an, China)

    Objective: The objective of this study was to ascertain level of cognitive function and its relationship with depression in American older adults with serious difficulty…
  • MDS Virtual Congress 2020

    CSF inflammatory cytokines and correlation with clinical features in early, untreated PD patients

    E. Olivola, M. Stampanoni Bassi, L. Gilio, C. Femiano, G. Ricciardo Rizzo, F. Sica, L. Belli, R. Furlan, A. Finardi, D. Centonze, N. Modugno (Pozzilli, Italy)

    Objective: The aims of the present study were to investigate the levels of inflammatory cytokines in the cerebrospinal fluid (CSF) of drug-naïve Parkinson's Disease (PD)…
  • MDS Virtual Congress 2020

    Non-pharmacological Treatment for Parkinson’s Disease Patients with Depression: A Meta-analysis of Repetitive Transcranial Magnetic Stimulation and Cognitive-Behavioral Treatment

    J.N Chen, P.K He, Y.H Zhang, YY. Gao, Y.H Qiu, Y. Li, Q.X Zhang, L.M Wang, J.H Zhao, K. Nie, L.J Wang (Guangzhou, China)

    Objective: This meta-analysis aims to assess the effect of non-pharmacological treatments for depression in patients with PD. Background: Antidepressants are the mainstay of treatment for…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 32
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An atypical and interesting feature of Parkinson´s disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • #23812 (not found)
  • Approaching Health Care Shaped by Generational Expectations (The AGE Study): Generational Perspective Related to Time
  • Application of the “5-2-1” Screening Criteria in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel: Interim Analysis from the DUOGLOBE Study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Decision-making process for opicapone’s bedtime regimen
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley